TENATHAN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Tenathan, and when can generic versions of Tenathan launch?
Tenathan is a drug marketed by Robins Ah and is included in one NDA.
The generic ingredient in TENATHAN is bethanidine sulfate. Additional details are available on the bethanidine sulfate profile page.
Summary for TENATHAN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 46 |
Patent Applications: | 839 |
DailyMed Link: | TENATHAN at DailyMed |
US Patents and Regulatory Information for TENATHAN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Robins Ah | TENATHAN | bethanidine sulfate | TABLET;ORAL | 017675-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Robins Ah | TENATHAN | bethanidine sulfate | TABLET;ORAL | 017675-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for TENATHAN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Robins Ah | TENATHAN | bethanidine sulfate | TABLET;ORAL | 017675-001 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
Robins Ah | TENATHAN | bethanidine sulfate | TABLET;ORAL | 017675-002 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |